首页 > 最新文献

Journal of the Saudi Heart Association最新文献

英文 中文
Intraoperative Remifentanil Use Reduces Atrial Fibrillation After Coronary Artery Bypass Surgery. 术中使用瑞芬太尼可减少冠状动脉搭桥手术后的心房颤动
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-17 eCollection Date: 2024-01-01 DOI: 10.37616/2212-5043.1390
Yasuhiko Imashuku, Susumu Hiraoka, Motoi Inoue, Takayoshi Mizuno, Misuzu Oyagi, Hirotoshi Kitagawa

Objectives: Atrial fibrillation after coronary artery bypass grafting is a relatively well known complication that has been observed for a long time. Though the management and drugs in the perioperative period have changed, their impact on the generation of postoperative atrial fibrillation remains unclear. Therefore, we investigated various perioperative management methods and the occurrence of postoperative atrial fibrillation.

Methods: The patients underwent off-pump coronary artery bypass grafting between January 2010 and October 2019. The study was a retrospective observational study, and we investigated the incidence of atrial fibrillation during all 5 postoperative days. Patient factors included age, sex, height, and weight, preoperative factors included oral statin, HbA1c, left ventricular ejection fraction, and left atrial diameter; intraoperative factors included operation time, remifentanil use, beta-blocker use, magnesium-containing infusions use, in-out balance, and number of vascular anastomoses.

Results: Postoperative atrial fibrillation was recognized in 81 out of 276 cases. There were significant differences between the two groups in terms of age, left atrial diameter, and intraoperative remifentanil use. A logistic regression analysis presented the effects of age (OR 1.045, 95% CI 1.015-1.076, P < 0.01), preoperative left atrial diameter (OR 1.072, 95% CI 1.023-1.124, P < 0.01), and intraoperative remifentanil use (OR 0.492, 95% CI 0.284-0.852, P = 0.011) on postoperative atrial fibrillation.

Conclusions: Operative time did not affect postoperative atrial fibrillation. Age and left atrial diameter had previously been shown to affect postoperative atrial fibrillation, and our results were similar. This study showed that the use of remifentanil reduced the incidence of postoperative atrial fibrillation. On the other hand, no other factors were found to have an effect.

目的:冠状动脉旁路移植术后的心房颤动是一种相对众所周知的并发症,已经观察了很长时间。虽然围手术期的管理和药物发生了变化,但它们对术后心房颤动发生的影响仍不明确。因此,我们研究了各种围手术期管理方法和术后心房颤动的发生率:患者于 2010 年 1 月至 2019 年 10 月间接受了体外循环冠状动脉搭桥术。该研究是一项回顾性观察研究,我们调查了术后5天内心房颤动的发生率。患者因素包括年龄、性别、身高和体重,术前因素包括口服他汀类药物、HbA1c、左心室射血分数和左心房直径;术中因素包括手术时间、瑞芬太尼使用情况、β-受体阻滞剂使用情况、含镁输液使用情况、出入量平衡和血管吻合次数:结果:276个病例中有81个发现术后心房颤动。两组患者在年龄、左心房直径和术中使用瑞芬太尼方面存在明显差异。逻辑回归分析显示了年龄(OR 1.045,95% CI 1.015-1.076,P <0.01)、术前左房直径(OR 1.072,95% CI 1.023-1.124,P <0.01)和术中使用瑞芬太尼(OR 0.492,95% CI 0.284-0.852,P = 0.011)对术后房颤的影响:手术时间对术后心房颤动没有影响。结论:手术时间对术后心房颤动没有影响。年龄和左心房直径曾被证明会影响术后心房颤动,我们的结果与之相似。本研究表明,使用瑞芬太尼可降低术后心房颤动的发生率。另一方面,没有发现其他因素有影响。
{"title":"Intraoperative Remifentanil Use Reduces Atrial Fibrillation After Coronary Artery Bypass Surgery.","authors":"Yasuhiko Imashuku, Susumu Hiraoka, Motoi Inoue, Takayoshi Mizuno, Misuzu Oyagi, Hirotoshi Kitagawa","doi":"10.37616/2212-5043.1390","DOIUrl":"10.37616/2212-5043.1390","url":null,"abstract":"<p><strong>Objectives: </strong>Atrial fibrillation after coronary artery bypass grafting is a relatively well known complication that has been observed for a long time. Though the management and drugs in the perioperative period have changed, their impact on the generation of postoperative atrial fibrillation remains unclear. Therefore, we investigated various perioperative management methods and the occurrence of postoperative atrial fibrillation.</p><p><strong>Methods: </strong>The patients underwent off-pump coronary artery bypass grafting between January 2010 and October 2019. The study was a retrospective observational study, and we investigated the incidence of atrial fibrillation during all 5 postoperative days. Patient factors included age, sex, height, and weight, preoperative factors included oral statin, HbA1c, left ventricular ejection fraction, and left atrial diameter; intraoperative factors included operation time, remifentanil use, beta-blocker use, magnesium-containing infusions use, in-out balance, and number of vascular anastomoses.</p><p><strong>Results: </strong>Postoperative atrial fibrillation was recognized in 81 out of 276 cases. There were significant differences between the two groups in terms of age, left atrial diameter, and intraoperative remifentanil use. A logistic regression analysis presented the effects of age (OR 1.045, 95% CI 1.015-1.076, P < 0.01), preoperative left atrial diameter (OR 1.072, 95% CI 1.023-1.124, P < 0.01), and intraoperative remifentanil use (OR 0.492, 95% CI 0.284-0.852, P = 0.011) on postoperative atrial fibrillation.</p><p><strong>Conclusions: </strong>Operative time did not affect postoperative atrial fibrillation. Age and left atrial diameter had previously been shown to affect postoperative atrial fibrillation, and our results were similar. This study showed that the use of remifentanil reduced the incidence of postoperative atrial fibrillation. On the other hand, no other factors were found to have an effect.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"36 3","pages":"232-236"},"PeriodicalIF":0.7,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11373418/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142140425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Saudi Heart Association/National Heart Center/Saudi Arabian Cardiac Interventional Society/Saudi Society for Cardiac Surgeons/Saudi Cardiac Imaging Group 2023 TAVI Guidelines. 沙特心脏协会/国家心脏中心/沙特阿拉伯心脏介入学会/沙特心脏外科医师学会/沙特心脏成像小组 2023 年 TAVI 指南。
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-15 eCollection Date: 2024-01-01 DOI: 10.37616/2212-5043.1379
Turki Albacker, Adel Tash, Hussein Alamri, Mirvat Alasnag, Wail Alkashkari, Fawaz Almutairi, Faisal Alqoofi, Ahmed Alsaileek, Uthman Aluthman, Ghormallah Alzahrani, Mohammed Balghith, Fahd Makhdom

Saudi Arabia has seen a significant improvement in its healthcare system over the past four decades resulting in an increase in life-expectancy. Transcatheter aortic valve implantation (TAVI) has spread widely in Saudi Arabia and has become a routine procedure in many centers. The expanding clinical indications and the availability of the technology have made it possible for many large and intermediate centers all over the country to commence their own TAVI programs. So, the aim of this document is to standardize TAVI practices in different Saudi Arabian centers through reasonable guidelines based on the evaluation and summarization of the best available evidence. The review committee, composed of different experts in several aspects of the management of patient undergoing TAVI, based their recommendations on the reviewed and analyzed evidence and the class and level of recommendations were discussed until a consensus was reached by the panel.

在过去的四十年里,沙特阿拉伯的医疗保健系统得到了显著改善,延长了患者的预期寿命。经导管主动脉瓣植入术(TAVI)已在沙特阿拉伯广泛开展,并已成为许多中心的常规手术。随着临床适应症的不断扩大和技术的普及,全国许多大型和中型中心都开始了自己的 TAVI 项目。因此,本文件的目的是在评估和总结现有最佳证据的基础上,通过合理的指南来规范沙特阿拉伯不同中心的 TAVI 操作。评审委员会由接受 TAVI 患者管理多个方面的不同专家组成,他们根据审查和分析的证据提出建议,并对建议的类别和级别进行讨论,直至小组达成共识。
{"title":"Saudi Heart Association/National Heart Center/Saudi Arabian Cardiac Interventional Society/Saudi Society for Cardiac Surgeons/Saudi Cardiac Imaging Group 2023 TAVI Guidelines.","authors":"Turki Albacker, Adel Tash, Hussein Alamri, Mirvat Alasnag, Wail Alkashkari, Fawaz Almutairi, Faisal Alqoofi, Ahmed Alsaileek, Uthman Aluthman, Ghormallah Alzahrani, Mohammed Balghith, Fahd Makhdom","doi":"10.37616/2212-5043.1379","DOIUrl":"10.37616/2212-5043.1379","url":null,"abstract":"<p><p>Saudi Arabia has seen a significant improvement in its healthcare system over the past four decades resulting in an increase in life-expectancy. Transcatheter aortic valve implantation (TAVI) has spread widely in Saudi Arabia and has become a routine procedure in many centers. The expanding clinical indications and the availability of the technology have made it possible for many large and intermediate centers all over the country to commence their own TAVI programs. So, the aim of this document is to standardize TAVI practices in different Saudi Arabian centers through reasonable guidelines based on the evaluation and summarization of the best available evidence. The review committee, composed of different experts in several aspects of the management of patient undergoing TAVI, based their recommendations on the reviewed and analyzed evidence and the class and level of recommendations were discussed until a consensus was reached by the panel.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"36 2","pages":"184-231"},"PeriodicalIF":0.7,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11373420/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142133042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"Two is Company, Three is a Crowd" - A Case Presentation of Cardiac Amyloidosis, Hypertrophic Cardiomyopathy Plus Coronary Heart Disease. "二人为伴,三人成群"--心脏淀粉样变性、肥厚性心肌病加冠心病的病例介绍。
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-12 eCollection Date: 2024-01-01 DOI: 10.37616/2212-5043.1389
Carolina M Gonçalves, Mariana Carvalho, Célia Domingues, Fátima Saraiva, João Morais

A 76-year-old man was referred to our appointment with complaints of exertional dyspnea. He had a medical history consisting of chronic coronary syndrome, hypertrophic cardiomyopathy, and an implantable cardioverter-defibrillator for primary prevention. A transthoracic echocardiogram revealed features suspicious for cardiac amyloidosis. Haematologic and genetic tests were negative, and scintigraphy was positive, confirming wild-type transthyretin amyloidosis, not eligible for tafamidis. Several months later with optimized medical therapy, he had two worsening heart failure events. This clinical case highlights the importance of differential diagnosis. Our patient had both hypertrophic cardiomyopathy and transthyretin amyloidosis, a rare association that constitutes a diagnostic and treatment challenge.

一名 76 岁的男性因主诉劳累性呼吸困难而被转诊至我院。他的病史包括慢性冠状动脉综合征、肥厚型心肌病和用于一级预防的植入式心律转复除颤器。经胸超声心动图显示,他有心脏淀粉样变性的可疑特征。血液学和基因检测均为阴性,闪烁扫描呈阳性,证实为野生型转甲状腺素淀粉样变性,不符合他法米迪治疗条件。几个月后,经过优化的药物治疗,他出现了两次心力衰竭恶化。这个临床病例强调了鉴别诊断的重要性。我们的患者同时患有肥厚型心肌病和经淀粉样蛋白淀粉样变性,这种罕见的合并症给诊断和治疗带来了挑战。
{"title":"\"Two is Company, Three is a Crowd\" - A Case Presentation of Cardiac Amyloidosis, Hypertrophic Cardiomyopathy Plus Coronary Heart Disease.","authors":"Carolina M Gonçalves, Mariana Carvalho, Célia Domingues, Fátima Saraiva, João Morais","doi":"10.37616/2212-5043.1389","DOIUrl":"10.37616/2212-5043.1389","url":null,"abstract":"<p><p>A 76-year-old man was referred to our appointment with complaints of exertional dyspnea. He had a medical history consisting of chronic coronary syndrome, hypertrophic cardiomyopathy, and an implantable cardioverter-defibrillator for primary prevention. A transthoracic echocardiogram revealed features suspicious for cardiac amyloidosis. Haematologic and genetic tests were negative, and scintigraphy was positive, confirming wild-type transthyretin amyloidosis, not eligible for tafamidis. Several months later with optimized medical therapy, he had two worsening heart failure events. This clinical case highlights the importance of differential diagnosis. Our patient had both hypertrophic cardiomyopathy and transthyretin amyloidosis, a rare association that constitutes a diagnostic and treatment challenge.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"36 2","pages":"178-183"},"PeriodicalIF":0.7,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11518049/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142522229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spontaneous Interatrial Hematoma: Still an Unresolved Critical Conundrum. 自发性心房间血肿:仍是一个悬而未决的关键难题。
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-12 eCollection Date: 2024-01-01 DOI: 10.37616/2212-5043.1388
Fayaz M Khazi, Imthiaz Manoly, Nayyer R Siddiqi, Tarek A Aziz, Obaid Aljassim

Spontaneous interatrial hematoma is a rare clinical entity leading to the obliteration of the left atrial cavity and causing haemodynamic compromise, necessitating immediate surgical intervention. Herein, we report a patient with acute chest pain with normal coronaries and echocardiographic evidence of left atrial mass. The investigations revealed the mass to be a thrombus rather than tumour. The patient underwent surgery to remove a large thrombus completely enclosed within the interatrial septum. The septum was then repaired using a pericardial patch. No apparent etiological factor was found. Spontaneous atrial wall dissection should be considered in the differential diagnosis of acute chest pain.

自发性心房间血肿是一种罕见的临床病症,可导致左心房腔阻塞,造成血流动力学损害,必须立即进行手术干预。在此,我们报告了一名急性胸痛患者,其冠状动脉正常,超声心动图显示左心房肿块。检查发现肿块是血栓而非肿瘤。患者接受了手术,切除了完全封闭在房间隔内的大血栓。然后用心包补片修复了房间隔。没有发现明显的致病因素。在急性胸痛的鉴别诊断中应考虑自发性心房壁剥离。
{"title":"Spontaneous Interatrial Hematoma: Still an Unresolved Critical Conundrum.","authors":"Fayaz M Khazi, Imthiaz Manoly, Nayyer R Siddiqi, Tarek A Aziz, Obaid Aljassim","doi":"10.37616/2212-5043.1388","DOIUrl":"10.37616/2212-5043.1388","url":null,"abstract":"<p><p>Spontaneous interatrial hematoma is a rare clinical entity leading to the obliteration of the left atrial cavity and causing haemodynamic compromise, necessitating immediate surgical intervention. Herein, we report a patient with acute chest pain with normal coronaries and echocardiographic evidence of left atrial mass. The investigations revealed the mass to be a thrombus rather than tumour. The patient underwent surgery to remove a large thrombus completely enclosed within the interatrial septum. The septum was then repaired using a pericardial patch. No apparent etiological factor was found. Spontaneous atrial wall dissection should be considered in the differential diagnosis of acute chest pain.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"36 2","pages":"174-177"},"PeriodicalIF":0.7,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11518017/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142522233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consensus of National Heart Center and the Saudi Arabian Cardiac Interventional Society on the Current Landscape of the Management of Intracoronary Calcification in Saudi Arabia. 国家心脏中心和沙特阿拉伯心脏介入学会就沙特阿拉伯冠状动脉内钙化管理现状达成共识。
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-01 eCollection Date: 2024-01-01 DOI: 10.37616/2212-5043.1385
Khaled Al-Shaibi, Mirvat Alasnag, Owayed AlShemmari, Ayman AlSaleh, Wail AlKashkari, Fawaz AlMutairi, Nouf Alanazi, Mognee Alameer, Adel Tash

Objectives: We aimed to develop a streamlined algorithm for the management of intracoronary calcification that includes guidance on intracoronary imaging and the appropriate selection of atherectomy devices.

Methods: National experts representing both the National Heart Center (NHC) and the Saudi Arabian Cardiac Interventional Society (SACIS) met to develop a consensus document on the assessment and management of intracoronary calcification in Saudi Arabia. The nominal group technique was utilized; a number of statements on the assessment and management of coronary artery calcification were developed based on a systematic review of the literature. The authors discussed the developed statements until a consensus was reached.

Results: Twenty statements were discussed and agreed upon. Invasive and non-invasive imaging modalities in the assessment of coronary artery calcification, and management of intracoronary calcification using calcium ablation techniques, excimer laser coronary atherectomy, ballon-based techniques, and shockwave lithotripsy; were all thoroughly discussed in light of scientific evidence and the experts' clinical practice.

Conclusions: We present a national consensus on the assessment and the multifaceted management of intracoronary calcification in Saudi Arabia.

目的:我们旨在为冠状动脉内钙化的治疗制定一种简化算法,其中包括冠状动脉内成像指导和适当选择动脉粥样硬化切除装置:我们旨在为冠状动脉内钙化的治疗制定一个简化算法,其中包括冠状动脉内成像和适当选择动脉粥样硬化切除术设备的指导:代表国家心脏中心(NHC)和沙特阿拉伯心脏介入学会(SACIS)的国内专家召开会议,就沙特阿拉伯冠状动脉内钙化的评估和管理制定共识文件。会议采用了名义小组技术;在对文献进行系统回顾的基础上,制定了一系列关于冠状动脉钙化评估和管理的声明。作者们对制定的声明进行了讨论,直至达成共识:结果:对 20 项声明进行了讨论并达成一致。根据科学证据和专家的临床实践,对评估冠状动脉钙化的侵入性和非侵入性成像模式,以及使用钙消融技术、准分子激光冠状动脉粥样硬化切除术、球囊技术和冲击波碎石术治疗冠状动脉内钙化进行了深入讨论:我们就沙特阿拉伯冠状动脉内钙化的评估和多方面管理达成了全国共识。
{"title":"Consensus of National Heart Center and the Saudi Arabian Cardiac Interventional Society on the Current Landscape of the Management of Intracoronary Calcification in Saudi Arabia.","authors":"Khaled Al-Shaibi, Mirvat Alasnag, Owayed AlShemmari, Ayman AlSaleh, Wail AlKashkari, Fawaz AlMutairi, Nouf Alanazi, Mognee Alameer, Adel Tash","doi":"10.37616/2212-5043.1385","DOIUrl":"10.37616/2212-5043.1385","url":null,"abstract":"<p><strong>Objectives: </strong>We aimed to develop a streamlined algorithm for the management of intracoronary calcification that includes guidance on intracoronary imaging and the appropriate selection of atherectomy devices.</p><p><strong>Methods: </strong>National experts representing both the National Heart Center (NHC) and the Saudi Arabian Cardiac Interventional Society (SACIS) met to develop a consensus document on the assessment and management of intracoronary calcification in Saudi Arabia. The nominal group technique was utilized; a number of statements on the assessment and management of coronary artery calcification were developed based on a systematic review of the literature. The authors discussed the developed statements until a consensus was reached.</p><p><strong>Results: </strong>Twenty statements were discussed and agreed upon. Invasive and non-invasive imaging modalities in the assessment of coronary artery calcification, and management of intracoronary calcification using calcium ablation techniques, excimer laser coronary atherectomy, ballon-based techniques, and shockwave lithotripsy; were all thoroughly discussed in light of scientific evidence and the experts' clinical practice.</p><p><strong>Conclusions: </strong>We present a national consensus on the assessment and the multifaceted management of intracoronary calcification in Saudi Arabia.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"36 2","pages":"158-173"},"PeriodicalIF":0.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11518036/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142522231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardioprotective Efficacy of Sevoflurane in Patients With Rheumatic Heart Disease Undergoing Heart Valve Surgery Under Cardiopulmonary Bypass. 七氟醚对在心肺旁路下接受心脏瓣膜手术的风湿性心脏病患者的心脏保护作用
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-01 eCollection Date: 2024-01-01 DOI: 10.37616/2212-5043.1384
Vu T Lam, Nguyen Q Kinh, Nguyen M Ly

Objectives: In this study, we investigated whether cardioprotective properties of sevoflurane were expressed in patients with rheumatic heart disease undergoing heart valve surgery under cardiopulmonary bypass (CPB).

Methods: Fifty patients with rheumatic heart disease undergoing heart valve surgery under CPB were randomly assigned to receive total anesthesia with sevoflurane or propofol during surgery. Except for this, anesthetic and surgical management was the same in all patients. The primary outcomes were postoperative high-sensitive cardiac troponin T (hs-cTnT) and creatine kinase-myocardial band (CK-MB) release. The secondary outcomes were hemodynamic events and short-term clinical outcomes (within 30 days after surgery).

Results: The plasma concentrations of hs-cTnT at 24-hour and CK-MB from 6-hour to 48-hour in the sevoflurane group were lower than those in the control group (the propofol group). After aortic unclamping, heartbeat recovery was faster and the rate of sinus rhythm was higher in the sevoflurane group than in the control group. Moreover, a lower proportion of pacemaker use and the need for intraoperative and postoperative inotropes were also found in the sevoflurane group. Nevertheless, there were no differences between the two groups regarding short-term clinical outcomes (durations of mechanical ventilation, intensive care unit stay, hospital stay, morbidity, and mortality rates).

Conclusion: Sevoflurane administered during the entire anesthetic procedure had a myocardial protective effect with less evidence of myocardial damage in the first 48-hour postoperatively but short-term clinical outcomes were not significantly different when compared with the control group in patients with rheumatic heart disease undergoing heart valve surgery under CPB.

研究目的本研究探讨了七氟醚对在心肺旁路(CPB)下接受心脏瓣膜手术的风湿性心脏病患者是否具有心脏保护作用:方法:50 名风湿性心脏病患者在 CPB 下接受心脏瓣膜手术,他们被随机分配接受七氟醚或异丙酚全麻。除此以外,所有患者的麻醉和手术治疗方法相同。主要结果是术后高敏心肌肌钙蛋白 T(hs-cTnT)和肌酸激酶-心肌带(CK-MB)的释放。次要结果为血液动力学事件和短期临床结果(术后 30 天内):结果:七氟烷组 24 小时的 hs-cTnT 和 6 至 48 小时的 CK-MB 血浆浓度均低于对照组(异丙酚组)。与对照组相比,七氟醚组在主动脉缩窄后心跳恢复更快,窦性心律率更高。此外,七氟醚组使用起搏器的比例以及术中和术后肌注的需求也较低。尽管如此,两组在短期临床结果(机械通气时间、重症监护室住院时间、住院时间、发病率和死亡率)方面并无差异:结论:在CPB下接受心脏瓣膜手术的风湿性心脏病患者,在整个麻醉过程中使用七氟烷具有心肌保护作用,术后48小时内心肌损伤的证据较少,但短期临床结果与对照组相比没有显著差异。
{"title":"Cardioprotective Efficacy of Sevoflurane in Patients With Rheumatic Heart Disease Undergoing Heart Valve Surgery Under Cardiopulmonary Bypass.","authors":"Vu T Lam, Nguyen Q Kinh, Nguyen M Ly","doi":"10.37616/2212-5043.1384","DOIUrl":"10.37616/2212-5043.1384","url":null,"abstract":"<p><strong>Objectives: </strong>In this study, we investigated whether cardioprotective properties of sevoflurane were expressed in patients with rheumatic heart disease undergoing heart valve surgery under cardiopulmonary bypass (CPB).</p><p><strong>Methods: </strong>Fifty patients with rheumatic heart disease undergoing heart valve surgery under CPB were randomly assigned to receive total anesthesia with sevoflurane or propofol during surgery. Except for this, anesthetic and surgical management was the same in all patients. The primary outcomes were postoperative high-sensitive cardiac troponin T (hs-cTnT) and creatine kinase-myocardial band (CK-MB) release. The secondary outcomes were hemodynamic events and short-term clinical outcomes (within 30 days after surgery).</p><p><strong>Results: </strong>The plasma concentrations of hs-cTnT at 24-hour and CK-MB from 6-hour to 48-hour in the sevoflurane group were lower than those in the control group (the propofol group). After aortic unclamping, heartbeat recovery was faster and the rate of sinus rhythm was higher in the sevoflurane group than in the control group. Moreover, a lower proportion of pacemaker use and the need for intraoperative and postoperative inotropes were also found in the sevoflurane group. Nevertheless, there were no differences between the two groups regarding short-term clinical outcomes (durations of mechanical ventilation, intensive care unit stay, hospital stay, morbidity, and mortality rates).</p><p><strong>Conclusion: </strong>Sevoflurane administered during the entire anesthetic procedure had a myocardial protective effect with less evidence of myocardial damage in the first 48-hour postoperatively but short-term clinical outcomes were not significantly different when compared with the control group in patients with rheumatic heart disease undergoing heart valve surgery under CPB.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"36 2","pages":"120-127"},"PeriodicalIF":0.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11518043/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142522230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
To Evaluate Efficiency of Various Coronary Artery Disease Risk Scores With Traditional Risk Factors in Patients Undergoing Coronary Angiography. 在接受冠状动脉造影术的患者中评估各种冠状动脉疾病风险评分与传统风险因素的有效性。
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-12 eCollection Date: 2024-01-01 DOI: 10.37616/2212-5043.1386
Sharma Kamal, Panwar Jasraj, Patel Krutika, Parmar Devratsinh, Kalyani Maulik, Dhorajiya Dixit

Objective: To analyze and compare various cardiovascular disease risk scores in Western Indian patients undergoing Coronary angiogram (CAG).

Methods: In this prospective cross-sectional study, 1213 patients who underwent conventional coronary angiography; clinical risk profile and biochemical investigations were evaluated prior to undergoing CAG. Apart from the demographic information, 10-year absolute risk of having a major cardiovascular event (cardiovascular death, myocardial infarction or stroke) was calculated for each patient using various available Traditional Risk Scores (TRS). The population was divided in low, intermediate and high-risk categories for each of these scores.

Results: Traditional cardiovascular risk factors like hypertension (41.8%) and diabetes mellitus-II (26.9%) were the two most prevalent risk factors in our study population. A higher risk value for all these TRS was more likely to be associated with obstructive coronary artery disease (OCAD) on CAG. Patients with high risk (≥20% for 10-year) QRESEARCH (QRISK3) score category had higher number of patients with obstructive CAD (49.6%) as compared to high risk category of risk score for those with high Global Registry of Acute Coronary Events (GRACE) score (46.6%) or risk Framingham (FRS CHD) score (29.2%) and risk atherosclerotic cardiovascular disease (ASCVD) score (30.1%) (P < 0.0001). A higher TRS was more likely to be associated with obstructive CAD, with the highest predictability being with QRISK3 (QRISK3 score 60.9%, GRACE score 54.9%, FRS-CHD score 34% and ASCVD score 42.1% respectively; P < 0.0001). A substantial study population (27.4%) cannot be identified using any of these TRS and hence a need of indigenous or modified risk scores is proposed.

Conclusion: QRISK3 score was most efficacious for predicting obstructive CAD in our Indian study population on CAG. A higher risk score also correlated with the number of vessels involved on coronary angiogram. A substantial obstructive CAD patient could not be identified using traditional risk scores hence need for an indigenous or modified score.

目的分析并比较接受冠状动脉造影术(CAG)的印度西部患者的各种心血管疾病风险评分:在这项前瞻性横断面研究中,1213 名患者接受了常规冠状动脉造影术;在接受冠状动脉造影术前,对他们的临床风险概况和生化检查进行了评估。除人口统计学信息外,还使用各种可用的传统风险评分(TRS)计算了每位患者发生重大心血管事件(心血管死亡、心肌梗死或中风)的 10 年绝对风险。结果显示:传统的心血管风险因素如心肌梗死、心肌梗塞、心肌梗死或中风等占总人数的 40%:结果:高血压(41.8%)和 II 型糖尿病(26.9%)等传统心血管风险因素是研究人群中最普遍的两个风险因素。所有这些 TRS 的风险值越高,越可能与 CAG 上的阻塞性冠状动脉疾病(OCAD)有关。与全球急性冠状动脉事件登记(GRACE)高风险评分(46.6%)或弗雷明汉(FRS CHD)风险评分(29.2%)和动脉粥样硬化性心血管疾病(ASCVD)风险评分(30.1%)相比,QRESEARCH(QRISK3)高风险(10 年≥20%)评分类别的患者有更多的阻塞性 CAD 患者(49.6%)(P < 0.0001)。TRS越高越可能与阻塞性CAD有关,其中QRISK3的预测性最高(QRISK3评分为60.9%,GRACE评分为54.9%,FRS-CHD评分为34%,ASCVD评分为42.1%;P<0.0001)。有相当一部分研究对象(27.4%)无法使用这些TRS中的任何一种进行识别,因此建议需要使用本地的或经过修改的风险评分:结论:QRISK3 评分对预测印度 CAG 研究人群中的阻塞性 CAD 最有效。较高的风险评分也与冠状动脉造影中受累血管的数量相关。使用传统的风险评分法无法识别严重的阻塞性 CAD 患者,因此需要一种本土的或经过修改的评分法。
{"title":"To Evaluate Efficiency of Various Coronary Artery Disease Risk Scores With Traditional Risk Factors in Patients Undergoing Coronary Angiography.","authors":"Sharma Kamal, Panwar Jasraj, Patel Krutika, Parmar Devratsinh, Kalyani Maulik, Dhorajiya Dixit","doi":"10.37616/2212-5043.1386","DOIUrl":"10.37616/2212-5043.1386","url":null,"abstract":"<p><strong>Objective: </strong>To analyze and compare various cardiovascular disease risk scores in Western Indian patients undergoing Coronary angiogram (CAG).</p><p><strong>Methods: </strong>In this prospective cross-sectional study, 1213 patients who underwent conventional coronary angiography; clinical risk profile and biochemical investigations were evaluated prior to undergoing CAG. Apart from the demographic information, 10-year absolute risk of having a major cardiovascular event (cardiovascular death, myocardial infarction or stroke) was calculated for each patient using various available Traditional Risk Scores (TRS). The population was divided in low, intermediate and high-risk categories for each of these scores.</p><p><strong>Results: </strong>Traditional cardiovascular risk factors like hypertension (41.8%) and diabetes mellitus-II (26.9%) were the two most prevalent risk factors in our study population. A higher risk value for all these TRS was more likely to be associated with obstructive coronary artery disease (OCAD) on CAG. Patients with high risk (≥20% for 10-year) QRESEARCH (QRISK3) score category had higher number of patients with obstructive CAD (49.6%) as compared to high risk category of risk score for those with high Global Registry of Acute Coronary Events (GRACE) score (46.6%) or risk Framingham (FRS CHD) score (29.2%) and risk atherosclerotic cardiovascular disease (ASCVD) score (30.1%) (P < 0.0001). A higher TRS was more likely to be associated with obstructive CAD, with the highest predictability being with QRISK3 (QRISK3 score 60.9%, GRACE score 54.9%, FRS-CHD score 34% and ASCVD score 42.1% respectively; P < 0.0001). A substantial study population (27.4%) cannot be identified using any of these TRS and hence a need of indigenous or modified risk scores is proposed.</p><p><strong>Conclusion: </strong>QRISK3 score was most efficacious for predicting obstructive CAD in our Indian study population on CAG. A higher risk score also correlated with the number of vessels involved on coronary angiogram. A substantial obstructive CAD patient could not be identified using traditional risk scores hence need for an indigenous or modified score.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"36 2","pages":"128-136"},"PeriodicalIF":0.7,"publicationDate":"2024-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249062/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141620253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound-guided vs. Standard Coronary Access in Coronary Angiography: A Systematic Review and Meta-analysis. 冠状动脉造影中超声引导与标准冠状动脉入路的对比:系统回顾与元分析》。
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-10 eCollection Date: 2024-01-01 DOI: 10.37616/2212-5043.1383
Ibrahim Omer, Mohammed Bukhari, Mohammad Alsharif, Abdulrahman Alsamadani, Dinah Alahmadi, Ali S Alsudais, Abdullah Abdulkareem, Hashem A Alamir

Objectives: Coronary angiography is a procedure performed during cardiac catheterization to define the coronary anatomy and determine the extent of coronary artery disease (CAD). The use of a cheap, relatively available tool like an ultrasound machine to assist in vascular access might reduce the risks associated with blind access. This study aimed to explore the efficacy and associated complications of ultrasound-guided coronary artery catheterization.

Methods: This systematic review of randomized controlled trials (RCTs) was conducted according to the Preferred Reporting Item for Systematic Reviews and Meta-Analysis (PRISMA) and was registered in PROSPERO (CRD42022365518). A systematic search was performed for all published studies without language or country restrictions and all study variables were extracted into prefilled sheets by two independent reviewers.

Results: This meta-analysis identified 10 RCTs. The results confirmed statistically significantly reductions of total complications (RR = 0.53, 95% CI 0.39-0.72, P < .001), and hematoma >5 cm formation (RR = 0.43, 95% CI 0.25-0.75, P = 0.003) in patients who underwent ultrasound-guided coronary artery catheterization.

Conclusion: Ultrasound with catheterization, as opposed to landmark-based catheterization, significantly improved the peri-catheterization operative outcomes, providing evidence for further research to be conducted and consideration for its implementation within the medical setting.

目的:冠状动脉造影是在心导管检查过程中进行的一项程序,目的是确定冠状动脉解剖结构并确定冠状动脉疾病(CAD)的程度。使用像超声波机这样廉价、相对容易获得的工具来辅助血管通路可能会降低盲目通路带来的风险。本研究旨在探讨超声引导下冠状动脉导管术的疗效和相关并发症:这项随机对照试验(RCT)的系统综述是根据系统综述和荟萃分析的首选报告项目(PRISMA)进行的,并在 PROSPERO(CRD42022365518)上进行了注册。对所有已发表的研究进行了系统检索,没有语言或国家限制,所有研究变量均由两名独立审稿人提取到预填表中:这项荟萃分析确定了 10 项研究。结果证实,接受超声引导冠状动脉导管术的患者总并发症(RR = 0.53,95% CI 0.39-0.72,P < .001)和血肿 >5 厘米形成(RR = 0.43,95% CI 0.25-0.75,P = 0.003)明显减少:结论:超声引导导管术与基于标志物的导管术相比,能显著改善导管术周的手术效果,为进一步研究提供了证据,并可考虑在医疗环境中实施。
{"title":"Ultrasound-guided vs. Standard Coronary Access in Coronary Angiography: A Systematic Review and Meta-analysis.","authors":"Ibrahim Omer, Mohammed Bukhari, Mohammad Alsharif, Abdulrahman Alsamadani, Dinah Alahmadi, Ali S Alsudais, Abdullah Abdulkareem, Hashem A Alamir","doi":"10.37616/2212-5043.1383","DOIUrl":"10.37616/2212-5043.1383","url":null,"abstract":"<p><strong>Objectives: </strong>Coronary angiography is a procedure performed during cardiac catheterization to define the coronary anatomy and determine the extent of coronary artery disease (CAD). The use of a cheap, relatively available tool like an ultrasound machine to assist in vascular access might reduce the risks associated with blind access. This study aimed to explore the efficacy and associated complications of ultrasound-guided coronary artery catheterization.</p><p><strong>Methods: </strong>This systematic review of randomized controlled trials (RCTs) was conducted according to the Preferred Reporting Item for Systematic Reviews and Meta-Analysis (PRISMA) and was registered in PROSPERO (CRD42022365518). A systematic search was performed for all published studies without language or country restrictions and all study variables were extracted into prefilled sheets by two independent reviewers.</p><p><strong>Results: </strong>This meta-analysis identified 10 RCTs. The results confirmed statistically significantly reductions of total complications (RR = 0.53, 95% CI 0.39-0.72, P < .001), and hematoma >5 cm formation (RR = 0.43, 95% CI 0.25-0.75, P = 0.003) in patients who underwent ultrasound-guided coronary artery catheterization.</p><p><strong>Conclusion: </strong>Ultrasound with catheterization, as opposed to landmark-based catheterization, significantly improved the peri-catheterization operative outcomes, providing evidence for further research to be conducted and consideration for its implementation within the medical setting.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"36 2","pages":"111-118"},"PeriodicalIF":0.7,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249060/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141620254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epicardial Pacemaker Causing Cardiac Strangulation. 心外起搏器导致心脏绞窄。
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-08 eCollection Date: 2024-01-01 DOI: 10.37616/2212-5043.1378
Scott Kendall, Rihab Agouba, Andrew Sands, Frank Casey, Lars Nölke

Cardiac strangulation is a rare but potentially lethal complication of epicardial pacemaker insertion. We present the case of a 9-year-old girl who was identified as having cardiac strangulation on routine follow-up for an epicardial pacemaker inserted on day 1 of life for congenital complete heart block (CCHB). The potential clinical presentations and risk factors for pacemaker strangulation are then discussed.

心脏绞窄是心外起搏器植入术中一种罕见但可能致命的并发症。我们介绍了一例 9 岁女孩的病例,她在出生后第 1 天因先天性完全性心脏传导阻滞(CCHB)而植入心外膜起搏器,在常规随访中被发现患有心脏绞窄。然后讨论了起搏器扼死的潜在临床表现和风险因素。
{"title":"Epicardial Pacemaker Causing Cardiac Strangulation.","authors":"Scott Kendall, Rihab Agouba, Andrew Sands, Frank Casey, Lars Nölke","doi":"10.37616/2212-5043.1378","DOIUrl":"10.37616/2212-5043.1378","url":null,"abstract":"<p><p>Cardiac strangulation is a rare but potentially lethal complication of epicardial pacemaker insertion. We present the case of a 9-year-old girl who was identified as having cardiac strangulation on routine follow-up for an epicardial pacemaker inserted on day 1 of life for congenital complete heart block (CCHB). The potential clinical presentations and risk factors for pacemaker strangulation are then discussed.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"36 2","pages":"106-110"},"PeriodicalIF":0.7,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249059/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141620251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Author. 回复作者。
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-01 eCollection Date: 2024-01-01 DOI: 10.37616/2212-5043.1368
Walid Abukhudair, Ahmad Z Hafiz, Mohammed A Alosaimi, Fares A Alaynayn, Fahad A Alosaimi, Rehab A Karam, Tamer M Abdelrahman
{"title":"Reply to Author.","authors":"Walid Abukhudair, Ahmad Z Hafiz, Mohammed A Alosaimi, Fares A Alaynayn, Fahad A Alosaimi, Rehab A Karam, Tamer M Abdelrahman","doi":"10.37616/2212-5043.1368","DOIUrl":"https://doi.org/10.37616/2212-5043.1368","url":null,"abstract":"","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"36 2","pages":"93"},"PeriodicalIF":0.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249057/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141620252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Saudi Heart Association
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1